Side Effects of Prostate Cancer Treatments
Doctors follow a careful plan when treating prostate cancer, although it is still very difficult to avoid or limit the side effects of prostate cancer treatment. Prostate cancer treatment also damages the body's healthy tissues and cells, causing unwanted and often serious side effects.
The side effects of prostate cancer treatment are determined on the type and measure of treatment. The possible side effects of prostate cancer treatment will be explained by the doctors and nurses who deliver your care. Ways to help relieve the symptoms may also be suggested during and after prostate cancer treatment. If you experience any side effects, it is important to let your medical professional know.
Side effects following Prostate Cancer Surgery
The most common side effect following prostate cancer surgery is pain. Most patients' pain is controlled with medicine during the first days after surgery, although they still experience some discomfort. Pain relief should be discussed with the doctor or nurse. Many patients feel tired and have little energy for a while. The length or time each patient takes to recover varies from patient to patient.
The surgical removal of the prostate can cause permanent impotence and often causes urinary incontinence. However, these effects are becoming less common today due to new tumour removal methods being used. These techniques are known as nerve-sparing surgery and help prevent any permanent injury to the nerves which control the opening to the bladder and erection. This type of surgery is usually very successful and the urinary incontinence and impotence are only temporary. Since prostatectomy surgery prevents a man producing semen, their orgasms are dry.
Side Effects following Prostate Cancer Radiation Therapy
Radiation therapy has been known to cause patients severe fatigue. Great importance is placed upon resting, although doctors often advise those patients who have undergone radiation therapy to stay as active as possible. It is quite usual during external radiation therapy for the skin in the affected area to become dry, red and tender.
Hair loss in the pelvic area is also a common side effect of radiation therapy for this type of cancer. This can be in the temporary or permanent form, mainly depending on the type of radiation performed.
Radiation therapy can cause impotence, although this does not occur as often with radiation that has been performed internally. The nerves that control the erection are also less likely to become damaged through internal radiation.
Side effects following Prostate Cancer Hormone Therapy
Hormone therapy such as estrogen, Orchiectomy, LHRH agonist has often been found to cause side effects such as decline is sexual desire, hot flashes and impotence. LHRH agonist tends to increase the growth of tumours and make a man's symptoms worse. This problem is known as 'tumour flare' and is temporary. The drug does, however cause a man's testosterone levels to fall and without testosterone, the growth of tumours slow down and the condition improves. Oestrogen or Antiandrogen therapy often causes vomiting, nausea, swelling o tenderness or the breasts. Oestrogen is now used less in men as it increases the risk of problems with the heart.
Prostate cancer news on the Web
The Impact Of Urologic Diseases On The American Public Urologic conditions like urinary tract infections, kidney stones, and prostate cancer are a major economic burden on Americans, resulting in health care costs of close to $40 billion annually, according to a newly released national report that charts the demographic and economic impact of urologic diseases in the U.S... |
Distinct Molecular Subtype Of Prostate Cancer Discovered A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute... |
Hormone-Depleting Drug Shows Promise Against Localized High-Risk Prostate Tumors A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), June 1-5, in Chicago... |
Racial Disparities Revealed In Prostate Cancer Surgery Black prostate cancer patients may not be getting the same quality of care as white patients, according to a first-of-its-kind study by researchers at Henry Ford Hospital who found racial disparities in the results of surgery to remove diseased prostates... |
Avoiding Repeat Biopsies In Prostate Cancer - MDxHealth Launches ConfirmMDx Each year, in the United States, more than 650,000 men receive a negative prostate biopsy result, with around 25-35% of these results being false negative. However, a new prostate cancer test has been launched by MdxHealth. The test - ConfirmMDx™ for Prostate Cancer - will help physicians identify which men have a true-negative prostate biopsy from those who may have occult cancer... |
Ancient Remedy Slows Prostate Tumor Cell Proliferation An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine. Caffeic acid phenethyl ester, or CAPE, is a compound isolated from honeybee hive propolis, the resin used by bees to patch up holes in hives... |
Prostate Cancer Stem Cells Identified Among Low-PSA Cells Prostate cancer cells that defy treatment and display heightened tumor-generating capacity can be identified by levels of prostate specific antigen (PSA) expressed in the tumor cells, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Cell Stem Cell... |
Gay Men And Minorities Have Poorer Quality Of Life After Prostate Cancer Treatment To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men choose a more-suitable treatment plan, researchers from Thomas Jefferson University Hospital conclude in a literature review published in Nature Reviews Urology... |
Boron-Nitride Nanotubes Show Potential In Cancer Treatment A new study has shown that adding boron-nitride nanotubes to the surface of cancer cells can double the effectiveness of Irreversible Electroporation, a minimally invasive treatment for soft tissue tumors in the liver, lung, prostate, head and neck, kidney and pancreas. Although this research is in the very early stages, it could one day lead to better therapies for cancer... |
Denosumab (Xgeva) Not Approved For Metastasis Prevention Amgen's application for expanded indications for denosumab (Xgeva) were turned down by the FDA (Food and Drug Administration) - the expanded indications were to include bone metastases prevention in patients with castration-resistant prostate cancer... |
Prostate Cancer Cells Destroyed By The Common Herb Oregano Oregano, the common pizza and pasta seasoning herb, has long been known to possess a variety of beneficial health effects, but a new study by researchers at Long Island University (LIU) indicates that an ingredient of this spice could potentially be used to treat prostate cancer, the second leading cause of cancer death in American men... |
Males With Mutated BRCA1 Breast Cancer Gene Have Higher Prostate Cancer Risk Men who carry the mutated BRCA1 gene have a four times greater chance of developing prostate cancer than other males, researchers from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust reported in the British Cancer Journal. The mutated BRCA1 is found in people with a family history of not only breast cancer, but ovarian cancer as well... |
Prostate Cancer And Radiation Therapies - The Need For Additional Treatments In the April 18 issue of JAMA, a study comparing traditional radiation therapy to treat localized prostate cancer with intensity-modulated radiation therapy (IMRT) and proton therapy reveals thats IMRT was linked to fewer gastrointestinal side effects, receipt of additional cancer treatments and hip fractures but to more erectile dysfunction, whilst those who received proton ... |
|